Iran's resolute commitment to combating the COVID-19 pandemic takes a momentous stride as the nation's pioneering mRNA coronavirus vaccine successfully completes its Phase 1 clinical trial, showcasing the potential to be recalibrated in response to evolving virus strains.
In a ceremony at Imam Khomeini hospital in Tehran, the clinical trial of the first domestically produced mRNA-based vaccine for the coronavirus started on Saturday.
–A health official has said different centers are working to develop existing vaccines in order to be used against new variants.
There is still the possibility that the eighth or even subsequent waves of coronavirus hit the country, but it highly depends on which variant of the virus will emerge, Mostafa Salehi Vaziri, head of the national laboratory for COVID-19 at the Pasteur Institute of Iran, has said.
A new wave of the coronavirus is currently sweeping the country and the seventh peak of the disease is expected to occur by October.
In a letter to the universities of medical sciences, the Ministry of Health emphasized the need to inject a booster dose of coronavirus vaccine, ISNA reported on Tuesday.
There will not be a new wave of coronavirus and a significant increase in the incidence of this disease over the next three months, Hamidreza Jamaati, secretary of the National Scientific Committee of Coronavirus, has said.
President Seyed Ebrahim Raisi stressed the need for the people to continue to pay attention to health protocols and called on the members of the National Task Force Against Coronavirus to try to convince the people to inject a third dose of the vaccine.
It seems the COVID-19 saga does not want to reach its finish line and its death toll is increasing every day and it has brought back concerns among the nations and this time through its new mutation Omicron.
The Ministry of Health has issued a license to export 20 percent of the domestically produced coronavirus vaccines, IRNA reported on Tuesday.